Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Antidiabetic Biguanides industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Merck & Co
Pfizer
Takeda Pharmaceuticals
Anderson Hay & Grain Inc
Sanofi
Novo Nordisk
Border Valley
AstraZeneca
Eli Lilly
Bristol-Myers Squibb
By Type:
Metformin SR
Metformin IR
By Application:
Clinic
Hospital
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Antidiabetic Biguanides Market Overview 2018-2029
-
1.1 China Antidiabetic Biguanides Industry Development Overview
-
1.2 China Antidiabetic Biguanides Industry Development History
-
1.3 China Antidiabetic Biguanides Industry Market Size (2018-2029)
-
1.4 China Antidiabetic Biguanides Market Analysis by Type from Production Side
-
1.4.1 China Antidiabetic Biguanides Production Volume, Production Value and Growth Rate of Metformin SR (2018-2029)
-
1.4.2 China Antidiabetic Biguanides Production Volume, Production Value and Growth Rate of Metformin IR (2018-2029)
-
1.5 China Antidiabetic Biguanides Market Analysis by Application from Consumption End
-
1.5.1 China Antidiabetic Biguanides Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)
-
1.5.2 China Antidiabetic Biguanides Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
1.6 China Antidiabetic Biguanides Market Analysis by Region
-
1.6.1 North China Antidiabetic Biguanides Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Antidiabetic Biguanides Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Antidiabetic Biguanides Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Antidiabetic Biguanides Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Antidiabetic Biguanides Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Antidiabetic Biguanides Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Antidiabetic Biguanides Market Size and Growth Rate from 2018-2029
Chapter 2 China Antidiabetic Biguanides Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Antidiabetic Biguanides Market Status and Competition at home and abroad in 2023
-
2.2.2 China Antidiabetic Biguanides Market Status and Competition Analysis in 2023
-
2.2.3 China Antidiabetic Biguanides Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Antidiabetic Biguanides Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Antidiabetic Biguanides Industry Development
Chapter 3 Antidiabetic BiguanidesIndustry Chain Analysis
-
3.1 Antidiabetic Biguanides Industry Chain
-
3.2 Antidiabetic Biguanides Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Antidiabetic Biguanides Market
-
3.3 Antidiabetic Biguanides Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Antidiabetic Biguanides Market
Chapter 4 China Antidiabetic Biguanides Market, by Type
-
4.1 China Antidiabetic Biguanides Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Antidiabetic Biguanides Total Production Volume and Growth Rate from Production Side
-
4.5 China Antidiabetic Biguanides Production Volume and Growth Rate, by Type
-
4.5.1 China Antidiabetic Biguanides Production Volume and Growth Rate of Metformin SR
-
4.5.2 China Antidiabetic Biguanides Production Volume and Growth Rate of Metformin IR
Chapter 5 China Antidiabetic Biguanides Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Antidiabetic Biguanides Total Market Size and Growth Rate from Consumption End
-
5.5 China Antidiabetic Biguanides Market Size and Growth Rate, by Application
-
5.5.1 China Antidiabetic Biguanides Market Size and Growth Rate of Clinic
-
5.5.2 China Antidiabetic Biguanides Market Size and Growth Rate of Hospital
Chapter 6 China Antidiabetic Biguanides Market, by Region
-
6.1 China Antidiabetic Biguanides Production Volume and Production Value, by Region
-
6.2 China Antidiabetic Biguanides Sales Volume and Sales Value, by Region
Chapter 7 North China Antidiabetic Biguanides Market Analysis
-
7.1 North China Antidiabetic Biguanides Market, by Type
-
7.2 North China Antidiabetic Biguanides Market, by Application
Chapter 8 Central China Antidiabetic Biguanides Market Analysis
-
8.1 Central China Antidiabetic Biguanides Market, by Type
-
8.2 Central China Antidiabetic Biguanides Market, by Application
Chapter 9 South China Antidiabetic Biguanides Market Analysis
-
9.1 South China Antidiabetic Biguanides Market, by Type
-
9.2 South China Antidiabetic Biguanides Market, by Application
Chapter 10 East China Antidiabetic Biguanides Market Analysis
-
10.1 East China Antidiabetic Biguanides Market, by Type
-
10.2 East China Antidiabetic Biguanides Market, by Application
Chapter 11 Northeast China Antidiabetic Biguanides Market Analysis
-
11.1 Northeast China Antidiabetic Biguanides Market, by Type
-
11.2 Northeast China Antidiabetic Biguanides Market, by Application
Chapter 12 Southwest China Antidiabetic Biguanides Market Analysis
-
12.1 Southwest China Antidiabetic Biguanides Market, by Type
-
12.2 Southwest China Antidiabetic Biguanides Market, by Application
Chapter 13 Northwest China Antidiabetic Biguanides Market Analysis
-
13.1 Northwest China Antidiabetic Biguanides Market, by Type
-
13.2 Northwest China Antidiabetic Biguanides Market, by Application
Chapter 14 Company Profiles
-
14.1 Merck & Co
-
14.1.1 Merck & Co Company Profile
-
14.1.2 Merck & Co Antidiabetic Biguanides Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Pfizer
-
14.2.1 Pfizer Company Profile
-
14.2.2 Pfizer Antidiabetic Biguanides Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Takeda Pharmaceuticals
-
14.3.1 Takeda Pharmaceuticals Company Profile
-
14.3.2 Takeda Pharmaceuticals Antidiabetic Biguanides Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Anderson Hay & Grain Inc
-
14.4.1 Anderson Hay & Grain Inc Company Profile
-
14.4.2 Anderson Hay & Grain Inc Antidiabetic Biguanides Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Sanofi
-
14.5.1 Sanofi Company Profile
-
14.5.2 Sanofi Antidiabetic Biguanides Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Novo Nordisk
-
14.6.1 Novo Nordisk Company Profile
-
14.6.2 Novo Nordisk Antidiabetic Biguanides Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Border Valley
-
14.7.1 Border Valley Company Profile
-
14.7.2 Border Valley Antidiabetic Biguanides Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 AstraZeneca
-
14.8.1 AstraZeneca Company Profile
-
14.8.2 AstraZeneca Antidiabetic Biguanides Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Eli Lilly
-
14.9.1 Eli Lilly Company Profile
-
14.9.2 Eli Lilly Antidiabetic Biguanides Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Bristol-Myers Squibb
-
14.10.1 Bristol-Myers Squibb Company Profile
-
14.10.2 Bristol-Myers Squibb Antidiabetic Biguanides Market Performance
-
14.10.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Antidiabetic Biguanides Industry Research Conclusions
-
15.2 Antidiabetic Biguanides Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Antidiabetic Biguanides Industry Market Size (2018-2029)
-
Figure China Antidiabetic Biguanides Production Volume, Production Value and Growth Rate of Metformin SR (2018-2029)
-
Figure China Antidiabetic Biguanides Production Volume, Production Value and Growth Rate of Metformin IR (2018-2029)
-
Figure China Antidiabetic Biguanides Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)
-
Figure China Antidiabetic Biguanides Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
Figure North China Antidiabetic Biguanides Market Size and Growth Rate from 2018-2029
-
Figure Central China Antidiabetic Biguanides Market Size and Growth Rate from 2018-2029
-
Figure South China Antidiabetic Biguanides Market Size and Growth Rate from 2018-2029
-
Figure East China Antidiabetic Biguanides Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Antidiabetic Biguanides Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Antidiabetic Biguanides Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Antidiabetic Biguanides Market Size and Growth Rate from 2018-2029
-
Figure Antidiabetic Biguanides Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Antidiabetic Biguanides Market Share by Type in 2018
-
Figure China Antidiabetic Biguanides Market Share by Type in 2023
-
Figure China Antidiabetic Biguanides Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Antidiabetic Biguanides Production Volume and Growth Rate of Metformin SR (2018-2023)
-
Figure China Antidiabetic Biguanides Production Volume and Growth Rate of Metformin IR (2018-2023)
-
Figure China Antidiabetic Biguanides Market Share by Application in 2018
-
Figure China Antidiabetic Biguanides Market Share by Application in 2023
-
Figure China Antidiabetic Biguanides Total Market Size and Growth Rate from Consumption End
-
Figure China Antidiabetic Biguanides Market Size and Growth Rate of Clinic (2018-2023)
-
Figure China Antidiabetic Biguanides Market Size and Growth Rate of Hospital (2018-2023)
-
Table China Antidiabetic Biguanides Production Volume by Region (2018-2023)
-
Table China Antidiabetic Biguanides Production Volume Share by Region (2018-2023)
-
Figure China Antidiabetic Biguanides Production Volume Share by Region (2018-2023)
-
Table China Antidiabetic Biguanides Production Value by Region (2018-2023)
-
Table China Antidiabetic Biguanides Production Value Share by Region (2018-2023)
-
Figure China Antidiabetic Biguanides Production Value Share by Region (2018-2023)
-
Table China Antidiabetic Biguanides Sales Volume by Region (2018-2023)
-
Table China Antidiabetic Biguanides Sales Volume Share by Region (2018-2023)
-
Figure China Antidiabetic Biguanides Sales Volume Share by Region (2018-2023)
-
Table China Antidiabetic Biguanides Sales Value by Region (2018-2023)
-
Table China Antidiabetic Biguanides Sales Value Share by Region (2018-2023)
-
Figure China Antidiabetic Biguanides Sales Value Share by Region (2018-2023)
-
Table North China Antidiabetic Biguanides Production Volume by Type (2018-2023)
-
Table North China Antidiabetic Biguanides Production Volume Share by Type (2018-2023)
-
Figure North China Antidiabetic Biguanides Production Volume Share by Type (2018-2023)
-
Table North China Antidiabetic Biguanides Sales Volume by Application (2018-2023)
-
Table North China Antidiabetic Biguanides Sales Volume Share by Application (2018-2023)
-
Figure North China Antidiabetic Biguanides Sales Volume Share by Application (2018-2023)
-
Table Central China Antidiabetic Biguanides Production Volume by Type (2018-2023)
-
Table Central China Antidiabetic Biguanides Production Volume Share by Type (2018-2023)
-
Figure Central China Antidiabetic Biguanides Production Volume Share by Type (2018-2023)
-
Table Central China Antidiabetic Biguanides Sales Volume by Application (2018-2023)
-
Table Central China Antidiabetic Biguanides Sales Volume Share by Application (2018-2023)
-
Figure Central China Antidiabetic Biguanides Sales Volume Share by Application (2018-2023)
-
Table South China Antidiabetic Biguanides Production Volume by Type (2018-2023)
-
Table South China Antidiabetic Biguanides Production Volume Share by Type (2018-2023)
-
Figure South China Antidiabetic Biguanides Production Volume Share by Type (2018-2023)
-
Table South China Antidiabetic Biguanides Sales Volume by Application (2018-2023)
-
Table South China Antidiabetic Biguanides Sales Volume Share by Application (2018-2023)
-
Figure South China Antidiabetic Biguanides Sales Volume Share by Application (2018-2023)
-
Table East China Antidiabetic Biguanides Production Volume by Type (2018-2023)
-
Table East China Antidiabetic Biguanides Production Volume Share by Type (2018-2023)
-
Figure East China Antidiabetic Biguanides Production Volume Share by Type (2018-2023)
-
Table East China Antidiabetic Biguanides Sales Volume by Application (2018-2023)
-
Table East China Antidiabetic Biguanides Sales Volume Share by Application (2018-2023)
-
Figure East China Antidiabetic Biguanides Sales Volume Share by Application (2018-2023)
-
Table Northeast China Antidiabetic Biguanides Production Volume by Type (2018-2023)
-
Table Northeast China Antidiabetic Biguanides Production Volume Share by Type (2018-2023)
-
Figure Northeast China Antidiabetic Biguanides Production Volume Share by Type (2018-2023)
-
Table Northeast China Antidiabetic Biguanides Sales Volume by Application (2018-2023)
-
Table Northeast China Antidiabetic Biguanides Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Antidiabetic Biguanides Sales Volume Share by Application (2018-2023)
-
Table Southwest China Antidiabetic Biguanides Production Volume by Type (2018-2023)
-
Table Southwest China Antidiabetic Biguanides Production Volume Share by Type (2018-2023)
-
Figure Southwest China Antidiabetic Biguanides Production Volume Share by Type (2018-2023)
-
Table Southwest China Antidiabetic Biguanides Sales Volume by Application (2018-2023)
-
Table Southwest China Antidiabetic Biguanides Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Antidiabetic Biguanides Sales Volume Share by Application (2018-2023)
-
Table Northwest China Antidiabetic Biguanides Production Volume by Type (2018-2023)
-
Table Northwest China Antidiabetic Biguanides Production Volume Share by Type (2018-2023)
-
Figure Northwest China Antidiabetic Biguanides Production Volume Share by Type (2018-2023)
-
Table Northwest China Antidiabetic Biguanides Sales Volume by Application (2018-2023)
-
Table Northwest China Antidiabetic Biguanides Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Antidiabetic Biguanides Sales Volume Share by Application (2018-2023)
-
Table Merck & Co Company Profile
-
Table Merck & Co Antidiabetic Biguanides Revenue, Price and Gross (2018-2023)
-
Table Pfizer Company Profile
-
Table Pfizer Antidiabetic Biguanides Revenue, Price and Gross (2018-2023)
-
Table Takeda Pharmaceuticals Company Profile
-
Table Takeda Pharmaceuticals Antidiabetic Biguanides Revenue, Price and Gross (2018-2023)
-
Table Anderson Hay & Grain Inc Company Profile
-
Table Anderson Hay & Grain Inc Antidiabetic Biguanides Revenue, Price and Gross (2018-2023)
-
Table Sanofi Company Profile
-
Table Sanofi Antidiabetic Biguanides Revenue, Price and Gross (2018-2023)
-
Table Novo Nordisk Company Profile
-
Table Novo Nordisk Antidiabetic Biguanides Revenue, Price and Gross (2018-2023)
-
Table Border Valley Company Profile
-
Table Border Valley Antidiabetic Biguanides Revenue, Price and Gross (2018-2023)
-
Table AstraZeneca Company Profile
-
Table AstraZeneca Antidiabetic Biguanides Revenue, Price and Gross (2018-2023)
-
Table Eli Lilly Company Profile
-
Table Eli Lilly Antidiabetic Biguanides Revenue, Price and Gross (2018-2023)
-
Table Bristol-Myers Squibb Company Profile
-
Table Bristol-Myers Squibb Antidiabetic Biguanides Revenue, Price and Gross (2018-2023)
-
